Dr. Adebayo Lawal is a global expert in gene therapy and pharmaceutical development, with a proven track record leading clinical trials for rare genetic diseases. He has overseen successful drug approvals, including treatments for hemophilia, sickle cell disease, and thalassemia, and brings deep expertise across clinical development, regulatory strategy, and medical affairs. His work is driven by a passion for innovation and impact in underserved communities.